26 related articles for article (PubMed ID: 21968461)
1. Prevalence and factors associated with advanced HIV disease among young people aged 15 - 24 years in a national referral hospital in Sierra Leone: A cross-sectional study.
Baldeh M; Kizito S; Lakoh S; Sesay D; Dennis F; Barrie U; Williams SA; Robinson DR; Lamontagne F; Amahowe F; Turay P; Sensory-Bahar O; Geng E; Ssewamala FM
medRxiv; 2023 Nov; ():. PubMed ID: 37986831
[TBL] [Abstract][Full Text] [Related]
2. Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort.
Garriga C; García de Olalla P; Miró JM; Ocaña I; Knobel H; Barberá MJ; Humet V; Domingo P; Gatell JM; Ribera E; Gurguí M; Marco A; Caylà JA;
PLoS One; 2015; 10(12):e0145701. PubMed ID: 26716982
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy of a rural community-based integrated intervention for prevention and management of chronic obstructive pulmonary disease: a cluster randomized controlled trial in China's rural areas.
Yuan X; Tao Y; Zhao JP; Liu XS; Xiong WN; Xie JG; Ni W; Xu YJ; Liu HG
Braz J Med Biol Res; 2015 Nov; 48(11):1023-31. PubMed ID: 26352697
[TBL] [Abstract][Full Text] [Related]
4. Socio-economic determinants of disease progression among HIV infected adults in Kenya.
Gitahi-Kamau NT; Kiarie JN; Mutai KK; Gatumia BW; Gatongi PM; Lakati A
BMC Public Health; 2015 Jul; 15():733. PubMed ID: 26227658
[TBL] [Abstract][Full Text] [Related]
5. Determinants of progression to AIDS and death following HIV diagnosis: a retrospective cohort study in Wuhan, China.
Jiang H; Xie N; Cao B; Tan L; Fan Y; Zhang F; Yao Z; Liu L; Nie S
PLoS One; 2013; 8(12):e83078. PubMed ID: 24376638
[TBL] [Abstract][Full Text] [Related]
6. Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.
Fokam J; Billong SC; Bissek AC; Kembou E; Milenge P; Abessouguie I; Nkwescheu AS; Tsomo Z; Aghokeng AF; Ngute GD; Ndumbe PM; Colizzi V; Elat JB
BMC Public Health; 2013 Apr; 13():308. PubMed ID: 23565992
[TBL] [Abstract][Full Text] [Related]
7. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
9. [Socio-demographic factors associated with the progression of HIV infection and the impact of HAART in a seroconverter cohort in Madrid (1986-2009)].
Monge S; Del Romero J; Rodríguez C; de Mendoza C; de Górgolas M; Cosín J; Dronda F; Pérez-Cecilia E; Peña JM; Santos I; Rubio R; Del Amo J;
Enferm Infecc Microbiol Clin; 2012 Mar; 30(3):117-23. PubMed ID: 22014512
[TBL] [Abstract][Full Text] [Related]
10. [Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].
Pezzotti P; Dorrucci M; Donisi A; Cusini M; Mazzarello G; De Luca A; Salassa B; Ursitti MA; Giuliani M; Rezza G;
Epidemiol Prev; 2003; 27(6):348-55. PubMed ID: 15058363
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.
García de la Hera M; Ferreros I; del Amo J; García de Olalla P; Pérez Hoyos S; Muga R; del Romero J; Guerrero R; Hernández-Aguado I;
J Epidemiol Community Health; 2004 Nov; 58(11):944-50. PubMed ID: 15483312
[TBL] [Abstract][Full Text] [Related]
12. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
Jarrin I; Lumbreras B; Ferreros I; Pérez-Hoyos S; Hurtado I; Hernández-Aguado I
Int J Epidemiol; 2007 Feb; 36(1):187-94. PubMed ID: 17085455
[TBL] [Abstract][Full Text] [Related]
13. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
14. Educational level and HIV disease progression before and after the introduction of HAART: a cohort study in 989 HIV seroconverters in Spain.
Monge S; Jarrín I; Pérez-Hoyos S; Ferreros I; García-Olalla P; Muga R; Del Romero J; Belda J; Castilla J; Bolúmar F; Del Amo J;
Sex Transm Infect; 2011 Dec; 87(7):571-6. PubMed ID: 21968461
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]